Journal
MOLECULAR CELL
Volume 38, Issue 4, Pages 539-550Publisher
CELL PRESS
DOI: 10.1016/j.molcel.2010.03.015
Keywords
-
Categories
Funding
- Cancer Research Society (CRS/SRC)
- Canadian Cancer Society Research Institute (CCSRI/NCI-C)
- Canadian Institutes of Health Research (CIHR)
- FRSQ (Quebec)
Ask authors/readers for more resources
The p14/p19(ARF) (ARF) product of the CDKN2A gene displays tumor suppressor activity both in the presence and absence of p53/TP53. In p53-negative cells, ARF arrests cell proliferation, at least in part, by suppressing ribosomal RNA synthesis. We show that ARF does this by controlling the subnuclear localization of the RNA polymerase I transcription termination factor, TTF-I. TTF-I shuttles between nucleoplasm and nucleolus with the aid of the chaperone NPM/B23 and a nucleolar localization sequence within its N-terminal regulatory domain. ARF inhibits nucleolar import of TTF-I by binding to this nucleolar localization sequence, causing the accumulation of TTF-I in the nucleoplasm. Depletion of TTF-I recapitulates the effects of ARF on ribosomal RNA synthesis and is rescued by the introduction of a TTF-I transgene. Thus, our data delineate the pathway by which ARF regulates ribosomal RNA synthesis and provide a compelling explanation for the role of NPM.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available